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Local anesthetics induce autophagy in young permanent tooth
pulp cells
H Zhuang1,2,6, D Hu3,6, D Singer2, JV Walker2, RB Nisr4, K Tieu4, K Ali2, C Tredwin2, S Luo4, S Ardu5 and B Hu2
Pulp cells are essential for tooth development, and dentin repair and regeneration. In addition these cells have been identiﬁed
as an important stem cell source. Local anesthetics are widely used in dental clinics, as well as the other clinical disciplines
and have been suggested to interfere with human permanent tooth development and induce tooth agenesis through unknown
mechanisms. Using pig model and human young permanent tooth pulp cells, our research has identiﬁed that the local
anesthetics commonly used in clinics can affect cell proliferation. Molecular pathway proﬁling suggested that LC3II is one of
the earliest molecules induced by the agents and p62 is the only common downstream target identiﬁed for all the drugs tested.
The effect of the drugs could be partially recovered by V-ATPase inhibitor only if early intervention is performed. Our results
provide novel evidence that local anesthetics could affect tooth cell growth that potentially can have impacts on tooth
development.
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INTRODUCTION
Dental treatment involves similar or more frequent use of local
anesthesia compared with any other clinical discipline. Local
anesthetics are known to work by binding to voltage-gated Na+
channels in nerves, therefore block sodium transportation and
nerve conduction.1 Although the maximum doses of various local
anesthetics are established, the side effects of these agents on
dental tissues have not yet been fully investigated. The only
relevant literature in this regard relates to a canine model, which
reported that local anesthetics could accumulate in natural cavities
such as the crypts of tooth buds and the mandibular canal.2
A recent clinical epidemiological study showed that local anesthesia
can potentially interferes with human permanent tooth develop-
ment and induces tooth agenesis through unknown mechanisms.3
Autophagy is a catabolic process involving the degradation of
unnecessary or aberrant cellular components through hydrolysis
of lysosomes. It therefore controls the turnover of organelles and
proteins within cells, and of cells within organisms.4 During this
process, targeted cytoplasmic constituents are isolated within
autophagosomes, which then fuse with lysosomes to form
autolysosomes where the cellular material is degraded or
recycled.4 It was previously observed that anesthesia drugs could
induce vacuolation.5 However, neither the mechanisms respon-
sible for vacuolation nor its consequence has been reported.
Vacuoles have a major role in autophagy and maintain a balance
between biogenesis (production) and degradation (or turnover)
for many substances and cellular structures.
In this study, using a pig model and in vitro human cell culture,
we systematically tested the local concentrations of the agents
and the cellular effects and molecular interactions of several local
anesthetics routinely used in dental clinics.
RESULTS
Local anesthetics remain at high concentration in tooth pulp cells
after nerve block injection
The 5-month-old pig we used had a mixed dentitions including
deciduous teeth and young permanent teeth, as well as
developing third permanent molar tooth that are similar to
adolescent children. We decided to test ﬁve commercial
anesthetic drugs that are commonly used in the clinics of the
four dental schools involved in this study: articaine-based agents:
Ubistesin, Ubistesin forte and Septanest; mepivacaine-based
agent: Scandonest and Lidocaine based agent: Xylocaine.
Fluorescein-labeled local anesthetics were injected either
around mandibular foramen (for lidocaine) for nerve block
(Supplementary Figure 1A) or under the mucosa of the mesial
buccal and lingual periapical regions of the ﬁrst molar (for
Ubistasin and Scandonest, not shown) for inﬁltration, exactly
simulating clinical situations. It is noticeable that with nerve block,
local anesthetics were able to penetrate into developing third
molar in a posterior–anterior direction (Supplementary Figure 1B),
with a concentration of 19.88 ± 14.19 mM at the posterior site and
8.72 ± 9.43mM at the anterior site 2 h after injection and could
reach to 16.39 ± 8.36 mM and 22.23 ± 17.45 mM respectively after
16 h inside the two proximities of the tooth (Supplementary
Figure 1C and E). In contrast, at 2 h, the inﬁltration injection could
reach to very high concentration at the outermost cell layer
of the tooth pulp with 49.54 ± 22.57 mM for Ubistesin and
21.16±15.44mM for Scandonest (Supplementary Figures 1D and E).
However, notably the inner layer cells had much lower concentrations
of the drugs at 6.67 ± 7.21 mM for Ubistesin and 9.89 ± 10.28 mM
for Scandonest (Supplementary Figures 1D and E). Contrary
to nerve block methods, in inﬁltration injection, the drug
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concentration rapidly decreased after 16 h with the outermost
cell layer only held 16.65 ± 10.70 mM for Ubistesin and
9.89 ± 10.28 mM for Scandonest, whereas in the inner cell layer
of the tooth pulps the drugs were entirely eliminated
(Supplementary Figures 1C and E).
Local anesthetics affect tooth pulp cell proliferation in a dose-
dependent manner
As we found that local anesthetics remained high concentrations
particularly in the nerve block method even after 16 h although
the test was not performed in vivo. We then decided to test the
dose effect of the agents on tooth pulp cells by measuring cell
proliferation, differentiation and apoptosis, the key parameters
that control tooth germ tissue and cell development. At increasing
concentrations of the drugs tested, there was a signiﬁcant dose-
dependent reduction of Ki67 mRNA expression (Figure 1a).
In contrast, there was no change in the levels of cell differentiation
and cell death upon anesthetic challenge in mRNA expression for
the tooth pulp differentiation markers Runx2 and p38, and the
apoptosis marker Bax at different concentrations (Figure 1b and d,
Xylocaine also showed similar regulation pattern of the markers
tested, data not shown). The TUNEL assay conﬁrmed that
apoptosis was not induced by these drugs (data not shown).
Local anesthetics induce autophagy in tooth pulp cells
In parallel to the decreased cell proliferation, in the presence of all
the drugs, increased vacuole formation was also observed in the
cytoplasm of dental pulp cells (Figure 2a and data not shown).
Immunoﬂuorescence analysis showed that the vacuoles contained
LAMP-1 (Figure 2b and Supplementary Figure 2A). As LAMP-1
overexpression is often associated with an accumulation of
autophagic vacuoles, we therefore measured the level of
autophagy. Autophagosome numbers correlate with the levels
of autophagosome-associated protein LC3-II or the number of
Figure 1. Local anesthetics affect tooth pulp cell proliferation but not differentiation and apoptosis. Real-time RT-PCR analysis of Ki67 (a), Runx2
(b), p38 (c) and Bax (d) mRNA expression in cells treated with increasing concentrations of the drugs tested for 16 h, normalized to expression
of the 36β4 housekeeping gene. TUNEL analysis was performed on the same samples and no differences of apoptosis index have been found
(data not shown). UBI, Ubistesin; UBI-F, Ubistesin forte; Scan, Scandonest; Sept, Septanest.
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Figure 2. Local anesthetics induce autophagy in tooth pulp cells. (a) Phase-contrast microscopy images of drug-treated and control cells.
(b and c) Immunoﬂuorescence analysis of LAMP-1 and LC3 (red) expression in control cells and cells treated with 2mM anesthetic drug.
(d) Western blot (left panel) analysis of LC3 expression in two primary dental pulp cell lines with and without drug treatment. Note that LC3 is
expressed as two isoforms with molecular weights 17 kDa (LC3-II) and 19 kDa (LC3-I). β-Actin was used as a loading control. Signal
quantiﬁcation (right panel) was performed on C-DiGit Blot scanner acquired gel images using Image Studio 4.0 software (LI-COR Biosciences
UK Ltd, Cambridge, UK). Relative signal was calculated as LC3II (17 kDa) versus LC3I (19 kDa) then normalized against β-Actin signal. (e) GFP–
LC3 fusion protein expression (green) in control cells and cells treated with 0.5 mM anesthetic drug. Cells were counterstained for Phalloidin
(red). Cell nuclei were visualized using 4′,6-diamidino-2-phenylindole (DAPI). Additional analysis can be found in Supplementary Figure 2.
Scale bars, 20 μm. UBI, Ubistesin; UBI-F, Ubistesin forte; Scan, Scandonest; Sept, Septanest. Scale bars, 10 μm.
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LC3-positive vesicles.6 Immunoﬂuorescence microscopy (Figure 2c
and Supplementary Figure 2B) and immunoblotting (Figure 2d)
results showed that all anesthetics tested markedly increased
levels of LC3, particularly the short half-life form, LC3II (Figure 2d).
To provide further evidence of autophagy induction, we analyzed
GFP-positive vesicles in cells transfected with GFP–LC3 plasmids.
The results showed that GFP production was highly increased in
drugs-treated cells, suggesting that all of the local anesthetics
tested could induce autophagy (Figure 2e and data not shown).
Consistent with our in vitro ﬁndings, in the local-anesthetic-treated
pig mandibles, LC3II was indeed induced in the third molar
tooth pulps both at 2 and 16 h after nerve block injection
(Supplementary Figure 2C) and in the ﬁrst molar teeth received
inﬁltration injections, LC3II induction could only be mainly
identiﬁed at the outermost cell layer of the tooth pulp at 2 h
but was quickly removed after 16 h (Supplementary Figure 2D).
Early autophagy inhibition can reverse anti-cell proliferation
effects of local anesthetics on tooth pulp cells
To understand if the antiproliferative effect of the drugs is time
dependent, we performed BrdU labeling analysis of the cells
at 0.5 and 2mM concentrations. The results showed that local
anesthetics could already block cell proliferation at 2 h at a rate of
twofold change, whereas at 16 h most of the drugs reduced BrdU-
positive labeling by more than ﬁve times (Figure 3a). Western
blotting analysis of LC3, p62 and phosphorylated form mTor
Figure 3. Local anesthetics affect tooth pulp cell proliferation via autophagy induction. (a) BrdU labeling analysis in cells treated with 0.5 or
2mM concentrations of the ﬁve anesthetic drugs for 2, 4, 8 and 16 h. (b) Western blot analysis of LC3, p62 and mTOR protein levels in cells
treated with 2 mM concentration drugs. Similar results have been achieved with lidocaine (data not shown). The quantiﬁcation of the
individual experiment can be found in Supplementary Figures 3A. (c) Western blot analysis of LC3 protein levels in cells treated with 0.5 and
2mM concentrations of the indicated anesthetic drugs and together with 100 nM baﬁlomycin for 8 and 16 h. β-actin was used as a loading
control by stripping and reblotting the same blot. Additional experiments and the quantiﬁcations of the can be found in Supplementary
Figure 3c. (d) BrdU-positive cells indexing (four random ﬁelds were analyzed under × 10 lens in a Zeiss LSM510Meta laser-scanning
microscope, Carl Zeiss Ltd., Cambridge, UK) of the samples from the same experiments indicated in c and Supplementary Figure 3B. *Po0.05;
**Po0.01.
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suggested that LC3 is the earliest induced molecular by the local
anesthetics administration, whereas the induction of p62 and
p-mTor only became signiﬁcant after 8 h (Figure 3b and
supplementary Figure 3A), suggesting autophagosome formation
is among the earliest cellular reactions upon local anesthetic drug
challenge.
Autophagy has been reported to be able to reduce cell
proliferation.7 We therefore addressed this possibility by treating
cells with an autophagy inhibitor, baﬁlomycin that speciﬁcally
inhibits vacuolar-type H+ ATPase (V-ATPase)8 together with
each anesthetic drug at 0.5 and 2mM concentrations for 8 and
16 h. The results showed that at 8 h time point autophagy
inhibition did antagonize the antiproliferative effects of anes-
thetics on tooth pulp cells (Figure 3c and d and Supplementary
Figures 3B and C), while at 16 h, baﬁlomycin still had the
rescuing effects in the 0.5 mM agent treated group but failed to
do so in the 2mM group (Figure 3c and d and Supplementary
Figures 3B and C).
p62 is the key target of local anesthetics
To investigate which downstream molecular signaling pathways
mediate the effects of local anesthetics on tooth pulp cells, we
analyzed the changes in gene expression using the PCR array
(PathwayFinder) assay. p62 was the only gene to consistently
show dose-dependent changes in expression for all drugs tested
and at different concentrations (Figure 4a and Supplementary
Figure 4). Interestingly, transcriptional analysis of a panel of key
autophagy genes (including LC3) showed p62 was the only
common gene changed by all the drugs tested (Figure 4b).
Upregulation of p62 mRNA and protein was validated by real-time
RT-PCR and western blot analysis, respectively (Figure 4b and c).
Importantly, p62 mRNA and protein levels appeared to be linked
with local anesthetic concentrations (Figure 4c). In the same time-
course study (Figure 3a and b), we also found that p62 mRNA
could be already induced 2 h after the application of the drugs
(Figure 4d) but the protein level changes only happened at 8 and
16 h (Figure 3b), suggesting the upregulation of p62 was the
subsequent effect of LC3II induction.
Local anesthetics-induced cell growth arrest is not linked with
mitochondrial dysfunctions
Local anesthetics have been known to be able to induce cellular
stress and autophagy that has been linked with mitochondrial
dysfunctions. We therefore measured dynamic cellular energetics
Figure 4. p62 is the common downstream target of anesthetic drugs on tooth pulp cells. (a) Heatmap analysis of PCR array data showing
changes in gene expression in tooth pulp cells after 16 h treatment with indicated 2mM anesthetic drugs (for 0.5 mM dosage, please see
Supplementary Figure 4). Colors represent fold changes in expression, as shown in the key. (b) Real-time RT-PCR analysis of a panel of
autophagy-related genes in primary tooth pulp cells using speciﬁc primers, normalized to 36β4 housekeeping gene expression. Error bars
represent standard deviation of the triplicate experiments. (c) Western blot analysis of p62 expression in drug-treated cells. β-actin was used
as a loading control by stripping and reblotting the same blot. p62 signal quantiﬁcation was calculated with normalization against β-actin
signal (right panel). Similar results have been achieved with lidocaine both for western blot and gene proﬁling (data not shown). UBI,
Ubistesin; UBI-F, Ubistesin forte; Scan, Scandonest; Sept, Septanest. *Po0.05; **Po0.01. (d) Real-time RT-PCR analysis of p62 gene in tooth
pulp cells treated with the ﬁve anesthetics for different time periods, normalized to 36β4 housekeeping gene expression. Error bars represent
standard deviation of triplicate experiments.
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using the Seahorse XF reader in cells received local anesthetics
challenge. The results showed unexpectedly that at time points 2,
4 and 8 h, all the parameters tested including basal respiration,
phosphorylation, proton leak and maximum respiration were
induced in the agents treated cells for most of the cases
(Figures 5a and b and Supplementary Figures 5A and B) with
the exception of the 16-h time point at 2 mM but not 0.5 mM
concentration four out of ﬁve drugs tested reduced basal
respiration, phosphorylation and maximum respiration but not
proton leak (Figure 5a and b and Supplementary Figures 5A and
B). These results indicate that mitochondrial functions were
disturbed only at high concentration (2 mM) after 16 h.
DISCUSSION
Very little has been known about the impact of local anesthetics
on the tooth, particularly on young tooth pulp cells. Articaine,
mepivacaine and lidocaine are the most prevalent injectable local
anesthetic agents not only in dental clinics but also in other
practices. Among them, articaine has been used as the ﬁrst choice
by most of the dentists as it has been proven to be more efﬁcient
than the other drugs such as lidocaine due to better nerve
block and tooth pulpal anesthesia results.9,10 Articaine contains
a thiophene ring and mepivacaine and lidocaine contains
a benzene ring that can increase drug lipid solubility. Local
anesthetics are known to work by binding to voltage-gated Na+
Figure 5. Local anesthetics affect tooth pulp cellular energetics. Key parameters of mitochondrial function including basal respiration,
phosphorylation, proton leak and maximum respiration were tested by directly measuring the oxygen consumption rate (OCR) of cells treated
with the ﬁve anesthetics with 0.5 and 2mM concentrations for 2 h (a) and 16 h (b) (8, 16 h results can be found in Supplementary Figure 5).
Note that at 16 h basal respiration, phosphorylation and maximum respiration were all reduced in the 2mM UBI-F, Sept, Scan and Lido treated
cells. Lido, Lidocaine; UBI, Ubistesin; UBI-F, Ubistesin forte; Scan, Scandonest; Sept, Septanest. Number abbreviations after individual drug
abbreviation: 0.5: 0.5 mM; 2: 2 mM. *Po0.05; **Po0.01.
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channels in nerves, therefore block sodium transportation and
nerve conduction.1 To our knowledge, this is the ﬁrst systematic
analysis of the effects for these agents on tooth pulp cell activities.
The aim of our study was not to compare the similarities and
differences between the agents, but rather we wanted to
investigate on common effects of the drugs that potentially could
explain the clinically observed increased tooth agenesis ratio in
patients who receive local anesthesia treatment3 and we have
found that the drugs tested could inhibit tooth pulp cells
proliferation in vitro, in a dosage dependent manner.
It has been reported that local anesthetics such as bupivacaine
can uncouple mitochondrial oxygen consumption and ATP
synthesis and reduce ATP synthesis.11 Mepivacaine can also
inhibit mitochondrial respiration12 and lidocaine can cause
mitochondrial injury and induce apoptosis in the cells.13,14,15 We
noted as previously reported that local anesthesia drugs could
induce vacuolation.5 The vacuolation in human tooth pulp cells by
the drugs is linked with autophagy that can be monitored by
LC3II, a key autolysosomal marker.6 Using various approaches, we
have shown that the autophagy marker LC3-II levels were
increased in tooth pulp cells by local anesthetic drugs. Also by
applying a LC3-GFP reporter assay, we showed that the LC3
protein was translocated into autophagosomes when primary
tooth cells were treated with the anesthetic drugs.
Mechanistically, autophagy has often been linked with mito-
chondrial dysfunctions and localized inside mitochondria (i.e., also
named as mitophagy).16 However, through detailed dynamic
cellular energetic analysis we have identiﬁed that upon challenge
by the different drugs tested, at least until 8 h after treatment,
mitochondrial functions of tooth pulp cells were not diminished.
Instead we have observed a signiﬁcant increase of mitochondrial
respiration, a possible surviving mechanism have been initiated in
mitochondria to counteract the toxicity effect of the drugs. It is
noticeable that longer treatment at high but not low concentra-
tion for most of the tested drugs did reduce basal respiration,
phosphorylation and maximum respiration of mitochondria, in the
meantime, unexpectedly the mitochondrial spare respiratory
capacity remained unchanged (data not shown), suggesting at
this stage and condition mitochondrial functions have been
possibly damaged that require further experiments of checking
mitochondria integrity and functions are desired.
Interestingly proton leak has been identiﬁed in all the tested
drugs in all the conditions, suggesting it is a direct consequence of
local anesthetic drug application. In fact, another local anesthetic
drug bupivacaine has been found to have uncoupling function
through a protonophore-like mechanism;17 therefore, it would be
interesting to understand if articaine, mepivacaine and lidocaine
function on proton leak using the same machinery. Continuous H
vacuolar (V)-ATPase activity is required to maintain the pH in case
of proton leak.18 Given the fact that acidic lysosomal condition is
required for autophagosome maturation, we hypothesize that
V-Atpase’s function has been overactivated upon drug challenge.
Indeed, this hypothesis can be supported by the fact that adding
V-Atpase speciﬁc inhibitor, baﬁlomycin could efﬁciently rescue cell
proliferation. A future assay on V-Atpase activities would be
helpful to further prove our theory. Also for later stage high-
concentration drug treaments, baﬁlomycin failed to further induce
LC3II accumulation also suggest that future tests need to be done
on the other mechanisms involving in autophagy and dose effect
of baﬁlomycin.
A key role of autophagy is to remove excess aggresomes
associated p62 and dysfunctional organelles that can induce
double strand DNA breaks.18 p62 is a receptor for cargo destined
to be degraded by autophagy, including ubiquitinated protein
aggregates.19 The p62 protein can bind both ubiquitin and LC3,
thereby targeting ubiquitinated proteins to the autophagosome
for clearance.20 In addition, p62 has been shown to regulate cell
proliferation through Twist1 stabilization.7 Therefore, intracellular
p62 protein levels are critical for cell viability. Mechanistically,
using a signaling pathway speciﬁc PCR array, we identiﬁed the p62
gene as a unique downstream target of all the drugs tested. We
also found that the concentrations of anesthetic drugs are linked
with p62 protein levels especially for later stages, while reduced
cell proliferation by long time high-concentration local anesthetics
treatment could not be rescued using baﬁlomycin. This observa-
tion suggests it is possible DNA damage could be induced by
excess p62 when it reaches to a certain concentration and is not
cleared in time.
In conclusion, our ﬁndings that local anesthetics can induce
autophagy in tooth pulp cells have clinical implications, due to
their potential impacts on tooth development as well as
root formation and apical foramen closure. Future in vivo
validation of our ﬁndings will be plausible to further enhance




The commercial anesthetic drugs used in this study were articaine-based
agents: Ubistesin (522721, 3 M ESPE), Ubistesin forte (512987, 3 M ESPE),
Septanest (09091451103, Septodont) and mepivacaine-based agent:
Scandonest (09091173002, Septodont) and Lidocaine based agent:
Xylocaine (Batch 4180, Dentsply).
Animal model of local anesthetics application
Freshly isolated mandibles from 5 months old Gloucester Old Spot crossed
with Landrace pigs (kindly provided by a local abattoir) were used in the
experiments. Local anesthetics: Lidocaine (for nerve block), Scandonest or
Ubistesin–Forte (for inﬁltration) was prelabeled with 0.5% ﬂuorescein. One
milliliter Lidocaine was then injected into the mandibular foramen and
0.8 ml Scandonest or Ubistesin–Forte was injected respectively into buccal
and lingual mesial submucous sites around the mesial apical root of
mandibular ﬁrst molars using 23G needle and 1-ml syringe. After 2 and
16 h, the third permanent molar tooth germ and the ﬁrst permanent molar
root pulp were excised and embedded in OCT compound (Tissue-Tek;
Sakura Finetek, Thatcham, UK). Eight-micrometer frozen sections were
prepared. The ﬂuorescence images of the tissues were acquired using a
Leica SP5 confocal microscope (Leica Microsystems (UK) Ltd, Breckland,
UK) and measured with Adobe Photoshop CS6 software (Adobe Systems
Europe Ltd, Maidenhead, UK) then normalized against the signal of the
labeled drugs.
Cell isolation and culture
Cell isolation and treatment protocols were approved by the Ethics
Committee of the Peking University School and Hospital of Stomatology,
Beijing, China. For details please see Supplementary Information.
Autophagy Inhibitor assay
A 10-mM stock solution of the autophagy inhibitor baﬁlomycin A1
(No. 11707, Sigma) was prepared in DMSO. Cells were treated with 100 nM
baﬁlomycin and control cells were treated with vehicle alone. For the
autophagy inhibition assay, cells were exposed to anesthetics and
baﬁlomycin at the same time.
Plasmid preparation and transfection
GFP–LC3II plasmids21 were used for visualization of autophagosome
formation. The GFP–LC3 fusion protein is expressed throughout the
cytoplasm in the absence of autophagy, but translocates to the
autophagosome membrane upon autophagy induction to form multiple
bright green ﬂuorescent spots. For details please see Supplementary
Information.
BrdU staining and quantiﬁcation
BrdU (RPN201, Amersham-GE) was diluted in complete cell culture
medium at a ratio of 1 : 1000 and added on top of tooth pulp cells for
2 h. Cells were then ﬁxed in 4% PFA then treated with of 2 N HCl for 30min
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before they were stained with anti-BrdU antibodies (ab6326, Abcam,
1 : 500 dilution). The antibody staining procedures were exactly as above
except the blocking buffer was prepared with 2.5% BSA. After imaging, the
images were processed in Image J software (National Institutes of Health,
Bethesda, MD, USA) and BrdU-positive cells and total cell number were
quantiﬁed using ‘Analyze Particles’ function.
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay
Apoptosis was assayed using an In Situ Cell Death Detection Kit
(11 684 795 910, Roche), following the manufacturer’s standard protocol.
Immunostaining, western blotting real-time RT-PCR and result
analysis
Immunostaining, western blotting, RNA and cDNA preparation, real-time
RT-PCR, and statistical analysis were performed as previously described.22
For experimental details please see Supplementary Information.
PCR array
Changes in human signal transduction genes were measured using an
RT2 Proﬁler PCR Array (Human Signal Transduction PathwayFinder;
PAHS-014ZG-4, Qiagen Ltd., Manchester, UK) on a Lightcycler 480
Instrument II (Roche Diagnostics Limited, Burgess Hill, UK) 384-well block
real-time PCR machine according to the manufacturer’s instructions. 1 μg
cDNA template was used for each sample. Results were exported into
Microsoft Excel and heatmap analysis was performed using Multiple
Experiment Viewer (MeV) 4.9.0 open source software (Dana-Farber Cancer
Institute, Boston, MA, USA).
Mitochondrial energetic assay
The XF Cell Mito Stress Test (#103015-100, Seahorse Bioscience, Copenhagen,
Denmark) was used in XF 96 Extracellular Flux Analyzer (Seahorse Bioscience)
to measure key parameters of mitochondrial function by directly
measuring the oxygen consumption rate (OCR) of live cells. For details
please see Supplementary Information.
Statistical analysis
PRISM 5 software (GraphPad Software, Inc. La Jolla, CA, USA) was used to
analyze the experimental data. One-way ANOVA followed by Bonferroni
correction was performed for real-time RT-PCR analysis, and Dunnett’s test
was applied for mitochondrial energetic analysis. Statistical signiﬁcance
was set at *Po0.05 and **Po0.01.
ABBREVIATIONS
36β4, ribosomal protein, large, P0; ACSL5, acetyl-CoA synthetase long-
chain family member 5; ADM, adrenomedullin; ARNT, aryl hydrocarbon
receptor nuclear translocator; ATG3, autophagy related 3; ATG5, autophagy
related 5; ATG7, autophagy related 7; ATG12, autophagy related 12; Bax,
B-cell chronic lymphocytic leukemia/lymphoma 2-associated X protein;
BBC3, B-cell chronic lymphocytic leukemia/lymphoma 2 binding compo-
nent 3; BCL2, B-cell chronic lymphocytic leukemia/lymphoma 2; BCL2A1,
B-cell chronic lymphocytic leukemia/lymphoma 2-related protein A1;
BIRC3, baculoviral inhibitor of apoptosis protein repeat containing 3;
BMP2, bone morphogenetic protein 2; BMP4, bone morphogenetic
protein 4; BrdU, bromodeoxyuridine; BSA, bovine serum albumin; CCL5,
chemokine (C–C motif) ligand 5; CCND2, cyclin D2; CDKN1A, cyclin-
dependent kinase inhibitor 1A; CDKN1B, cyclin-dependent kinase
inhibitor 1B; cDNA, complementary DNA; CEBPD, CCAAT/enhancer binding
protein, delta; CPT2, carnite palmitoyltransferase 2; CSF1, colony-
stimulating factor; DAB2, DAB, mitogen-responsive phosphoprotein
homolog 2; DAPI, 4′,6-diamidino-2-phenylindole dilactate; DMSO, dimethyl
sulfoxide; EGFR, epidermal growth factor receptor; EMP1, epithelial marker
protein 1; FCER2, Fc fragment of imuloglobulin E, low-afﬁnity II receptor;
FPSL1, farnesyl diphosphate synthase pseudogene 1; GATA3, GATA-
binding protein 3; GCLC, glutamate-cysteine ligase, catalytic subunit;
GCLM, glutamate–cysteine ligase, modiﬁer subunit; GFP, green ﬂuorescent
protein; GFP–LC3, green ﬂuorescent protein fused microtubule-associated
protein 1 light chain 3 alpha; GSR, glutathione reductase; HCl,
hydrochloric acid; HMOX1, heme oxygenase I; ICAM1, intercellular
adhesion molecule 1; ID1, Inhibitor of DNA Binding 1; IFNG,
Interferon Gama; Ki67, marker of proliferation Ki67; LAMP-1, lysosomal-
associated membrane protein 1; LC3, microtubule-associated protein
1A/1B-light chain 3; LC3 I, microtubule associated protein 1 light chain
cytosolic form; LC3 II, microtubule-associated protein 1 light-chain
membrane-bound form; Lido, lidocaine; MCL1, myeloid cell leukemia 1;
MeV, multiple experiment viewer; MMP7, matrix metallopeptidase 7; mTor,
mechanistic (or mammalian) target of rapamycin; MYC, myelogtomatosis
oncogene; NQO1, nicotinamide adenine dinucleotide phosphate dehy-
drogenase quinone1; OCR, oxygen consumption rate; OCT, optimum
cutting temperature; OLR1, oxidized low density lipoprotein (lectin-like)
receptor 1; P38, mitogen-activated protein kinase 14; P62, sequestosome 1;
PFA, paraformaldehyde; p-mTOR, phosphor-mechanistic (or mammalian)
target of rapamycin; PPARD, peroxisome proliferator-activated
receptor delta; PTCH1, Patched 1; RT-PCR, real-time PCR; Runx2, runt-
related transcription factor 2; Scan, Scandonest; Sep, Septanest; SLC27A4,
solute carrier family 27 (fatty acid transporter), member 4; SLC2A1, solute
carrier family 2 (facilitated glucose transporter), member 1; SOCS3,
suppressor of cytokine signaling 3; SQSTM1 (P62), Sequestosome 1; STAT1,
signal transducer and activator of transcription 1; TNF, tumor
necrosis factor; TNFSF10, tumor necrosis factor (ligand) superfamily,
member 10; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end
labeling; Twist1, twist family BHLH transcription factor 1; TXN, Thioredoxin;
TXNRD1, thioredoxin reductase 1; UBI, Ubistesin; UBI-F, ubistesin forte; V-
ATPase, vacuolar-type H+–ATPase; VEGFA, vascular endothelial growth
factor A; WNT2B, wingless-type MMTV integration site family, member 2B;
WNT3A, wingless-type MMTV integration site family, member 3A.
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